Kazazian Asset Management’s Bausch Health BHC Stock Holding History

Kazazian Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.77M	Buy	81,137 +21,825	+37%	+$499K	2.39%	14
2019 Q2	$1.5M	Sell	59,312 -6,208	-9%	-$147K	1.77%	18
2019 Q1	$1.62M	Sell	65,520 -2,601	-4%	-$62.1K	2.25%	16
2018 Q4	$1.26M	Sell	68,121 -61,663	-48%	-$1.47M	1.7%	17
2018 Q3	$3.33M	Sell	129,784 -5,000	-4%	-$114K	3.12%	10
2018 Q2	$3.13M	Buy	134,784 +18,814	+16%	+$389K	2.87%	11
2018 Q1	$1.85M	Sell	115,970 -11,597	-9%	-$216K	1.93%	15
2017 Q4	$2.65M	Buy	127,567 +50,256	+65%	+$797K	2.71%	8
2017 Q3	$1.11M	Hold	77,311	–	–	1.36%	18
2017 Q2	$1.34M	Hold	77,311	–	–	2.02%	12
2017 Q1	$853K	Buy	77,311 +42,146	+120%	+$580K	1.18%	15
2016 Q4	$511K	Buy	35,165 +10,500	+43%	+$193K	0.71%	22
2016 Q3	$606K	Buy	24,665 +14,500	+143%	+$375K	1.01%	21
2016 Q2	$205K	Sell	10,165 -8,550	-46%	-$242K	0.34%	30
2016 Q1	$492K	Buy	18,715 +14,815	+380%	+$1.1M	0.94%	17
2015 Q4	$396K	Buy	+3,900	New	+$438K	0.53%	26

Other funds holding BHC

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kazazian Asset Management's BHC Position: Q3 2019 in Review

Kazazian Asset Management increased its Bausch Health (BHC) stake by 37% in Q3 2019, buying an estimated $499K and bringing the position to 81,137 shares worth $1.77M. The position accounts for 2.39% of the portfolio, ranked #14.

Kazazian Asset Management first reported a position in BHC in Q4 2015 and has held it in 16 quarters since. The position peaked at $3.33M in Q3 2018. 315 funds tracked by Wall St. Rank hold BHC as of Q3 2019.

Kazazian Asset Management held 81,137 shares of Bausch Health worth $1.77M as of Q3 2019.
Kazazian Asset Management bought 21,825 Bausch Health shares in Q3 2019, an estimated $499K.
Bausch Health made up 2.39% of Kazazian Asset Management's portfolio in Q3 2019, its #14 holding.
Kazazian Asset Management first reported a position in Bausch Health in Q4 2015 and has held it in 16 quarters since.
Kazazian Asset Management's Bausch Health position peaked at $3.33M in Q3 2018.
315 funds tracked by Wall St. Rank held Bausch Health as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.